Colgate-Palmolive price target raised to $109 from $105 at UBS

UBS raised the firm’s price target on Colgate-Palmolive (CL) to $109 from $105 and keeps a Buy rating on the shares as part of a Q1 preview for the consumer staples group. With the exception of a few, it is clear the fundamental backdrop has deteriorated in recent weeks, driven by weaker consumer demand and an uncertain tariff backdrop, the analyst tells investors in a research note. UBS thinks the setup into earnings season for staples is “particularly tricky.” It continues to favor companies where fundamental visibility is high or improving, irrespective of the stock’s valuation. The firm believes Coca-Cola (KO), Keurig Dr Pepper (KDP), Celsius (CELH), Monster Beverage (MNST), and Church & Dwight (CHD) are well positioned heading into earnings.